Radiotherapy and Conservative Surgery in the Locoregional Management of Merkel Cell Carcinoma: The British Columbia Cancer Agency Experience

Annals of Surgical Oncology

Volumn 23, Issue 2, 2016, Pages 573-578

  Harrington, Chris ^a   Kwan, Winkle ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOCAL EXCISION; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; OVERALL SURVIVAL; RADIATION DOSE; RECURRENCE RISK; RETROSPECTIVE STUDY; SALVAGE THERAPY; TREATMENT OUTCOME; TUMOR BIOPSY; WIDE EXCISION; ADJUVANT RADIOTHERAPY; BRITISH COLUMBIA; CANCER STAGING; CARCINOMA, MERKEL CELL; DISEASE MANAGEMENT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRITISH COLUMBIA; CARCINOMA, MERKEL CELL; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 84958162911     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4812-9     Document Type: Article

References (23)

1. Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer. 2008;113:2549–58.
2. Fields RC, Busam K, Chou JF, et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg. 2011;254:465–75.
3. Schwartz JL, Griffith KA, Lowe L, et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol. 2011;29:1036–41.
4. Stokes JB, Graw KS, Dengel LT, Swenson BR, Bauer TW, Slingluff CL Jr, Ledesma EJ. Patients with Merkel cell carcinoma tumors ≤1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol. 2009;27:3772–7.
5. Miller SJ, Alam M, Andersen J, et al. The NCCN Merkel Cell Carcinoma Panel. Merkel cell carcinoma. J Natl Compr Cancer Netw. 2009;7:322–32.
6. Zhan FQ, Packianatha VS, Zeitouni NC. Merkel cell carcinoma: a review of current advances. J Natl Compr Cancer Netw. 2009;7:333–9.
7. Nghiem P, McKee PH, Haynes HA (2001) Merkel cell (cutaneous neuroendocrine) carcinoma. In: Sober AJ, Haluska FG (eds), American Cancer Society Atlas of Clinical Oncology: Skin Cancer. Hamilton: BC Decker Inc., 127–41.
8. Calder, KB, Smoller BR. New insights into Merkel cell carcinoma. Adv Anat Pathol. 2010;17:155–61.
9. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300–9.
10. Kukko H, Bohling T, Koljonen V, et al. Merkel cell carcinoma—a population-based epidemiological study in Finland with a clinical series of 181 cases. Eur J Cancer. 2012;48:737–42.
11. Gillenwater AM, Hessel AC, Morrison WH, Burgess MA, Silva EG, Roberts D, Goepfert H. Merkel cell carcinoma of the head and neck—effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg. 2001;127:149–54.
12. Edge SB, Byrd DR, Compton CC, et al. (eds.) Merkel cell carcinoma. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010:315–23.
13. Ghadjar P, Kaanders JH, Poortmans P, et al. The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the rare cancer network. Int J Radiat Oncol Biol Phys. 2011;81: e583–91.
14. Harrington C, Kwan W. Outcomes of Merkel cell carcinoma treated with radiotherapy without radical surgical excision. Ann Surg Oncol. 2014;21:3401–5.
15. Jouary T, Leyral C, Dreno B, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol. 2012;23:1074–80.
16. Santamaria-Barria JA, Boland GM, Yeap BY, Nardi V, Dias-Santagata D, Cusack JC. Merkel cell carcinoma: 30-year experience from a single institution. Ann Surg Oncol. 2013;20:1365–73.
17. Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol. 2006;142:693–700.
18. Eng TY, Boersma MG, Fuller CD, Goytia V, Jones WE 3rd, Joyner M, Nguyen DD. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol. 2007;30:624–36.
19. Clark JR, Veness MJ, Gilbert R, O’Brien CJ, Gullane PJ. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck. 2007;29:249–57.
20. Balakrishnan V, Berry S, Stew B, Sizeland A. Benefits of combined modality treatment of Merkel cell carcinoma of the head and neck: single institution experience. J Laryngol Otol. 2013;127:1–9.
21. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol. 2007;25:1043–7.
22. Warner RE, Quinn MJ, Hruby G, Scolyer RA, Uren RF, Thompson JF. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol. 2008;15:2509–18.
23. Gupta SG, Wang LC, Peñas PF, Gellenthin M, Lee S, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma. Arch Dermatol. 2006;142:685–90.